Genetic variations in dopamine and inhibitory control: Lack of influence on action restraint

Behavioural Brain Research

Volumn 267, Issue , 2014, Pages 12-16

  Gurvich, C T ^a   Rossell, S L ^a,b  

^a Australia   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

BRAINnet; Comt; DAT1; DRD2; Go No Go; Inhibitory control

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; COMT PROTEIN, HUMAN; DRD2 PROTEIN, HUMAN; SLC6A3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMT GENE; CONTROLLED STUDY; CORRELATIONAL STUDY; DAT1 GENE; DNA EXTRACTION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRD2 GENE; EXPERIMENTAL COGNITIVE TEST; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INHIBITION (PSYCHOLOGY); INHIBITORY CONTROL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RESPONSE TIME; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; VARIABLE NUMBER OF TANDEM REPEAT; EXECUTIVE FUNCTION; GENETICS; GENOTYPING TECHNIQUE; NEUROPSYCHOLOGICAL TEST; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

ADULT; CATECHOL O-METHYLTRANSFERASE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EXECUTIVE FUNCTION; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; INHIBITION (PSYCHOLOGY); MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECEPTORS, DOPAMINE D2; TASK PERFORMANCE AND ANALYSIS;

EID: 84897045677     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.03.015     Document Type: Article

References (25)

1. Bari A., Robbins T.W. Inhibition and impulsivity. Behavioral and neural basis of response control. Prog Neurobiol 2013, 108:44-79.
2. Dalley J.W., Roiser J.P. Dopamine, serotonin and impulsivity. Neuroscience 2012, 215:42-58.
3. Congdon E., Canli T. A neurogenetic approach to impulsivity. J Pers 2008, 76:1447-1484.
4. Ghahremani D.G., Lee B., Robertson C.L., Tabibnia G., Morgan A.T., De Shetler N., et al. Striatal dopamine D(2)/D(3) receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci 2012, 32:7316-7324.
5. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003, 12:205-216.
6. Hirvonen M.M., Laakso A., Nagren K., Rinne J.O., Pohjalainen T., Hietala J. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 2009, 63:907-912.
7. Colzato L.S., van den Wildenberg W.P., Van der Does A.J., Hommel B. Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 2010, 170:782-788.
8. White M.J., Lawford B.R., Morris C.P., Young R.M. Interaction between DRD2 C957T polymorphism and an acute psychosocial stressor on reward-related behavioral impulsivity. Behav Genet 2009, 39:285-295.
9. Obeso I., Wilkinson L., Casabona E., Bringas M.L., Alvarez M., Alvarez L., et al. Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease. Exp Brain Res 2011, 212:371-384.
10. Bannon M.J., Michelhaugh S.K., Wang J., Sacchetti P. The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacol 2001, 11:449-455.
11. Mitchell R.J., Howlett S., Earl L., White N.G., McComb J., Schanfield M.S., et al. Distribution of the 3' VNTR polymorphism in the human dopamine transporter gene in world populations. Hum Biol 2000, 72:295-304.
12. VanNess S.H., Owens M.J., Kilts C.D. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 2005, 6:55.
13. van Dyck C.H., Malison R.T., Jacobsen L.K., Seibyl J.P., Staley J.K., Laruelle M., et al. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene, Journal of nuclear medicine: official publication. Soc Nucl Med 2005, 46:745-751.
14. Bedard A.C., Schulz K.P., Cook E.H., Fan J., Clerkin S.M., Ivanov I., et al. Dopamine transporter gene variation modulates activation of striatum in youth with ADHD. Neuroimage 2010, 53:935-942.
15. Cornish K.M., Manly T., Savage R., Swanson J., Morisano D., Butler N., et al. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry 2005, 10:686-698.
16. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004, 75:807-821.
17. Eagle D.M., Bari A., Robbins T.W. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and Go/No-Go tasks. Psychopharmacology (Berl) 2008, 199:439-456.
18. Colzato L.S., van den Wildenberg W.P., Hommel B. The genetic impact (C957T-DRD2) on inhibitory control is magnified by aging. Neuropsychologia 2013, 51:1377-1381.
19. Vrshek-Schallhorn S., Wahlstrom D., Benolkin K., White T., Luciana M. Affective bias and response modulation following tyrosine depletion in healthy adults. Neuropsychopharmacology 2006, 31:2523-2536.
20. Congdon E., Lesch K.P., Canli T. Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity. Am J Med Genet B: Neuropsychiatr Genet 2008, 147B:27-32.
21. Camicioli R.M., Wieler M., de Frias C.M., Martin W.R. Early, untreated Parkinson's disease patients show reaction time variability. Neurosci Lett 2008, 441:77-80.
22. Kuntsi J., Klein C. Intraindividual variability in ADHD and its implications for research of causal links. Curr Top Behav Neurosci 2011, 9:67-91.
23. Kollins S.H., Anastopoulos A.D., Lachiewicz A.M., FitzGerald D., Morrissey-Kane E., Garrett M.E., et al. SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families. Am J Med Genet B: Neuropsychiatr Genet 2008, 147B:1580-1588.
24. Nandam L.S., Hester R., Wagner J., Cummins T.D., Garner K., Dean A.J., et al. Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biol Psychiatry 2011, 69:902-904.
25. Cools R., D'Esposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 2011, 69:e113-e125.